207 related articles for article (PubMed ID: 27902884)
21. Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives.
Kono M; Oda T; Tawada M; Imada T; Banno Y; Taya N; Kawamoto T; Tokuhara H; Tomata Y; Ishii N; Ochida A; Fukase Y; Yukawa T; Fukumoto S; Watanabe H; Uga K; Shibata A; Nakagawa H; Shirasaki M; Fujitani Y; Yamasaki M; Shirai J; Yamamoto S
Bioorg Med Chem; 2018 Jan; 26(2):470-482. PubMed ID: 29258712
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists.
Chen L; Su M; Wu XZ; Wang DZ; Kang YY; Wang CG; Assani I; Wang MX; Zhao SF; Lv SM; Wang JW; Sun B; Li Y; Jin Q; Huang RZ; Liao ZX
Eur J Med Chem; 2022 Feb; 229():114065. PubMed ID: 34971876
[TBL] [Abstract][Full Text] [Related]
23. Discovery of N-indanyl benzamides as potent RORγt inverse agonists.
Tian J; Sun N; Yu M; Gu X; Xie Q; Shao L; Liu J; Liu L; Wang Y
Eur J Med Chem; 2019 Apr; 167():37-48. PubMed ID: 30743096
[TBL] [Abstract][Full Text] [Related]
24. Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists.
Meijer FA; Doveston RG; de Vries RMJM; Vos GM; Vos AAA; Leysen S; Scheepstra M; Ottmann C; Milroy LG; Brunsveld L
J Med Chem; 2020 Jan; 63(1):241-259. PubMed ID: 31821760
[TBL] [Abstract][Full Text] [Related]
25. Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
Wang Y; Yang T; Liu Q; Ma Y; Yang L; Zhou L; Xiang Z; Cheng Z; Lu S; Orband-Miller LA; Zhang W; Wu Q; Zhang K; Li Y; Xiang JN; Elliott JD; Leung S; Ren F; Lin X
Bioorg Med Chem; 2015 Sep; 23(17):5293-302. PubMed ID: 26277758
[TBL] [Abstract][Full Text] [Related]
26. Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds.
Shirai J; Tomata Y; Kono M; Ochida A; Fukase Y; Sato A; Masada S; Kawamoto T; Yonemori K; Koyama R; Nakagawa H; Nakayama M; Uga K; Shibata A; Koga K; Okui T; Shirasaki M; Skene R; Sang B; Hoffman I; Lane W; Fujitani Y; Yamasaki M; Yamamoto S
Bioorg Med Chem; 2018 Jan; 26(2):483-500. PubMed ID: 29262987
[TBL] [Abstract][Full Text] [Related]
27. Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt.
Leijten-van de Gevel IA; Brunsveld L
J Biol Chem; 2020 Jul; 295(27):9183-9191. PubMed ID: 32439807
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism.
Yuan CM; Chen HH; Sun NN; Ma XJ; Xu J; Fu W
Acta Pharmacol Sin; 2019 Nov; 40(11):1480-1489. PubMed ID: 31316175
[TBL] [Abstract][Full Text] [Related]
29. Discovery of [1,2,4]Triazolo[1,5-
Nakajima R; Oono H; Sugiyama S; Matsueda Y; Ida T; Kakuda S; Hirata J; Baba A; Makino A; Matsuyama R; White RD; Wurz RΡ; Shin Y; Min X; Guzman-Perez A; Wang Z; Symons A; Singh SK; Mothe SR; Belyakov S; Chakrabarti A; Shuto S
ACS Med Chem Lett; 2020 Apr; 11(4):528-534. PubMed ID: 32292560
[TBL] [Abstract][Full Text] [Related]
30. Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742.
Gege C
Expert Opin Ther Pat; 2016 Jun; 26(6):737-44. PubMed ID: 26895086
[TBL] [Abstract][Full Text] [Related]
31. Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action.
Sun N; Xie Q; Dang Y; Wang Y
J Med Chem; 2021 Aug; 64(15):10519-10536. PubMed ID: 34264059
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
[TBL] [Abstract][Full Text] [Related]
33. Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.
Steeneck C; Gege C; Kinzel O; Albers M; Kleymann G; Schlüter T; Schulz A; Xue X; Cummings MD; Fourie AM; Leonard KA; Scott B; Edwards JP; Hoffmann T; Goldberg SD
Bioorg Med Chem Lett; 2020 Jun; 30(12):127174. PubMed ID: 32334912
[TBL] [Abstract][Full Text] [Related]
34. Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
Gege C; Schlüter T; Hoffmann T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5265-7. PubMed ID: 25305688
[TBL] [Abstract][Full Text] [Related]
35. Discovery of carbazole carboxamides as novel RORγt inverse agonists.
Huang Y; Yu M; Sun N; Tang T; Yu F; Song X; Xie Q; Fu W; Shao L; Wang Y
Eur J Med Chem; 2018 Mar; 148():465-476. PubMed ID: 29477887
[TBL] [Abstract][Full Text] [Related]
36. Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists.
Sato A; Fukase Y; Kono M; Ochida A; Oda T; Sasaki Y; Ishii N; Tomata Y; Fukumoto S; Imai YN; Uga K; Shibata A; Yamasaki M; Nakagawa H; Shirasaki M; Skene R; Hoffman I; Sang BC; Snell G; Shirai J; Yamamoto S
ChemMedChem; 2019 Nov; 14(22):1917-1932. PubMed ID: 31659845
[TBL] [Abstract][Full Text] [Related]
37. Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.
Ruan Z; Park PK; Wei D; Purandare A; Wan H; O'Malley D; Stachura S; Perez H; Cavallaro CL; Weigelt CA; Sack JS; Ruzanov M; Khan J; Gururajan M; Wong JJ; Huang Y; Yarde M; Li Z; Chen C; Sun H; Borowski V; Xie JH; Anthony M; Agler M; Fink BE; Harikrishnan LS
Bioorg Med Chem Lett; 2021 Mar; 35():127778. PubMed ID: 33422603
[TBL] [Abstract][Full Text] [Related]
38. Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists.
Jiang B; Duan JJ; Stachura S; Karmakar A; Hemagiri H; Raut DK; Gupta AK; Weigelt CA; Khan J; Sack JS; Wu DR; Yarde M; Shen DR; Galella MA; Mathur A; Zhao Q; Salter-Cid LM; Carter PH; Dhar TGM
Bioorg Med Chem Lett; 2020 Sep; 30(17):127392. PubMed ID: 32738966
[TBL] [Abstract][Full Text] [Related]
39. A reversed sulfonamide series of selective RORc inverse agonists.
van Niel MB; Fauber BP; Cartwright M; Gaines S; Killen JC; René O; Ward SI; de Leon Boenig G; Deng Y; Eidenschenk C; Everett C; Gancia E; Ganguli A; Gobbi A; Hawkins J; Johnson AR; Kiefer JR; La H; Lockey P; Norman M; Ouyang W; Qin A; Wakes N; Waszkowycz B; Wong H
Bioorg Med Chem Lett; 2014 Dec; 24(24):5769-5776. PubMed ID: 25453817
[TBL] [Abstract][Full Text] [Related]
40. Discovery of biaryl carboxylamides as potent RORγ inverse agonists.
Chao J; Enyedy I; Van Vloten K; Marcotte D; Guertin K; Hutchings R; Powell N; Jones H; Bohnert T; Peng CC; Silvian L; Hong VS; Little K; Banerjee D; Peng L; Taveras A; Viney JL; Fontenot J
Bioorg Med Chem Lett; 2015 Aug; 25(15):2991-7. PubMed ID: 26048806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
